Graeme J. Sills

9.6k total citations · 1 hit paper
95 papers, 4.4k citations indexed

About

Graeme J. Sills is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Graeme J. Sills has authored 95 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Psychiatry and Mental health, 53 papers in Cellular and Molecular Neuroscience and 43 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Graeme J. Sills's work include Epilepsy research and treatment (73 papers), Neuroscience and Neuropharmacology Research (52 papers) and Pharmacological Effects and Toxicity Studies (41 papers). Graeme J. Sills is often cited by papers focused on Epilepsy research and treatment (73 papers), Neuroscience and Neuropharmacology Research (52 papers) and Pharmacological Effects and Toxicity Studies (41 papers). Graeme J. Sills collaborates with scholars based in United Kingdom, United States and Italy. Graeme J. Sills's co-authors include Martin J. Brodie, Michael A. Rogawski, Martin J. Brodie, Elaine Butler, Patrick Kwan, Nikolas Hitiris, Rajiv Mohanraj, Linda J. Stephen, Gerard Forrest and John Norrie and has published in prestigious journals such as The Lancet, PLoS ONE and Neurology.

In The Last Decade

Graeme J. Sills

95 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of action of currently used antiseizure drugs

2020 317 citations Graeme J. Sills et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Graeme J. Sills United Kingdom	35	2.6k	1.9k	1.7k	894	541	95	4.4k
Henrik Klitgaard Belgium	50	3.6k 1.4×	2.3k 1.2×	3.6k 2.1×	2.1k 2.3×	329 0.6×	108	7.2k
Piero Perucca Australia	29	2.8k 1.1×	1.5k 0.8×	1.6k 0.9×	712 0.8×	183 0.3×	139	4.7k
Agostino Baruzzi Italy	47	2.1k 0.8×	1.5k 0.8×	1.2k 0.7×	2.2k 2.4×	370 0.7×	200	7.2k
Rita Citraro Italy	41	1.2k 0.5×	555 0.3×	1.5k 0.9×	1.3k 1.4×	222 0.4×	141	3.9k
Marco Sifringer Germany	37	696 0.3×	1.6k 0.8×	1.0k 0.6×	1.4k 1.5×	147 0.3×	73	4.6k
Jaideep Kapur United States	43	2.5k 1.0×	1.3k 0.7×	4.0k 2.4×	1.8k 2.0×	105 0.2×	169	5.6k
Elinor Ben‐Menachem Sweden	52	6.1k 2.3×	5.0k 2.6×	3.3k 2.0×	790 0.9×	772 1.4×	149	9.2k
Allan L. Sherwin Canada	30	1.2k 0.5×	851 0.4×	1.3k 0.8×	877 1.0×	149 0.3×	92	3.1k
Nathalie Lambeng France	15	783 0.3×	526 0.3×	1.2k 0.7×	845 0.9×	121 0.2×	24	2.7k
Russell P. Saneto United States	31	799 0.3×	575 0.3×	560 0.3×	2.3k 2.6×	114 0.2×	112	4.1k

Countries citing papers authored by Graeme J. Sills

Since Specialization

Citations

This map shows the geographic impact of Graeme J. Sills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme J. Sills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme J. Sills more than expected).

Fields of papers citing papers by Graeme J. Sills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme J. Sills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme J. Sills. The network helps show where Graeme J. Sills may publish in the future.

Co-authorship network of co-authors of Graeme J. Sills

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme J. Sills. A scholar is included among the top collaborators of Graeme J. Sills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme J. Sills. Graeme J. Sills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sills, Graeme J.. (2023). Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies. Therapeutic Advances in Neurological Disorders. 16. 4223472088–4223472088. 14 indexed citations

Löscher, Wolfgang, Graeme J. Sills, & H. Steve White. (2021). The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?. Epilepsia. 62(3). 596–614. 48 indexed citations

Marson, Anthony G, Girvan Burnside, Richard Appleton, et al.. (2021). Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Health Technology Assessment. 25(75). 1–134. 10 indexed citations

Morris, Andrew P., et al.. (2020). Functional analysis of epilepsy‐associated variants in STXBP1/Munc18‐1 using humanized Caenorhabditis elegans. Epilepsia. 61(4). 810–821. 30 indexed citations

Mirza, Nasir, Graeme J. Sills, Munir Pirmohamed, & Anthony G Marson. (2017). Identifying new antiepileptic drugs through genomics-based drug repurposing. Human Molecular Genetics. 26(3). ddw410–ddw410. 37 indexed citations

Jaki, Thomas, Graeme J. Sills, Richard Appleton, et al.. (2016). Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation. CNS Drugs. 30(11). 1011–1017. 13 indexed citations

Mirza, Nasir, Richard Appleton, Sasha Burn, et al.. (2015). Identifying the biological pathways underlying human focal epilepsy: from complexity to coherence to centrality. Human Molecular Genetics. 24(15). 4306–4316. 20 indexed citations

Bloch, Katarzyna, Graeme J. Sills, Munir Pirmohamed, & Ana Alfirevic. (2014). Pharmacogenetics of Antiepileptic Drug-Induced Hypersensitivity. Pharmacogenomics. 15(6). 857–868. 37 indexed citations

Barker‐Haliski, Melissa, Graeme J. Sills, & H. Steve White. (2014). What Are the Arguments For and Against Rational Therapy for Epilepsy?. Advances in experimental medicine and biology. 813. 295–308. 31 indexed citations

10.

Petrovski, Slavé, Annie Roten, H. R. Miller, et al.. (2014). Validation of a multigenic model to predict seizure control in newly treated epilepsy. Epilepsy Research. 108(10). 1797–1805. 17 indexed citations

11.

Sills, Graeme J.. (2013). Classical mechanisms of action of antiepileptic drugs. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 2 indexed citations

12.

Sills, Graeme J.. (2011). Mechanisms of action of antiepileptic drugs. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 30(3). 259–72. 12 indexed citations

13.

Sills, Graeme J., John Paul Leach, Martin J. Brodie, et al.. (2009). Response to drug treatment in newly diagnosed epilepsy: A pilot study of 1H NMR- and MS-based metabonomic analysis. Epilepsy Research. 88(2-3). 189–195. 15 indexed citations

14.

Sills, Graeme J., Elaine Butler, George G. Thompson, & Martin J. Brodie. (2003). Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models. Seizure. 13(5). 287–295. 36 indexed citations

15.

Deckers, C. L. P., Pierre Genton, Graeme J. Sills, & D. Schmidt. (2003). Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Research. 53(1-2). 1–17. 80 indexed citations

16.

Sills, Graeme J., Elaine Butler, Gerard Forrest, et al.. (2003). Vigabatrin, but not Gabapentin or Topiramate, Produces Concentration‐related Effects on Enzymes and Intermediates of the GABA Shunt in Rat Brain and Retina. Epilepsia. 44(7). 886–892. 57 indexed citations

17.

Sills, Graeme J., et al.. (2002). Na+ channel effects of remacemide and desglycinyl-remacemide in rat cortical synaptosomes. European Journal of Pharmacology. 438(1-2). 63–68. 8 indexed citations

18.

Sills, Graeme J., Philip N. Patsalos, Elaine Butler, et al.. (2001). Visual field constriction. Neurology. 57(2). 196–200. 49 indexed citations

19.

Sills, Graeme J., et al.. (1997). Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain. European Journal of Pharmacology. 325(1). 35–40. 64 indexed citations

20.

Forrest, Gerard, Graeme J. Sills, John Paul Leach, & Martin J. Brodie. (1996). Determination of gabapentin in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 681(2). 421–425. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact